 |
|
|
|
Genomic Approaches to Understanding Disease and Enhancing Drug Development: Sept. 16
Join the WBBA on Sept. 16th at the Institute for Systems Biology for a
symposium focused on recent advances in scientific and medical genomic
research.
The completion of the Human Genome Project and subsequent
advancements in scientific understanding and research tools started the
ball rolling for drug discovery and development in the new "genomic
era," an era with the potential to transform the future of medical care.
Dr. Eric Schadt of Rosetta/Merck and Dr. Jerry Radich of the Fred
Hutchinson Cancer Research Center will present. Discussants will be Dr.
Lee Hood of the Institute for Systems Biology and Dr. Marshall Horwitz
of UW Medicine.
 Register Today!
2008 Governor's Life Sciences Summit
Please join us at the Fourth Annual Governor's Life Sciences Summit on Monday, Sept. 22 at McCaw Hall at Seattle Center. The annual summit will include a review of progress toward the Life Science Discovery Fund activities, a peek at five exciting therapeutic advances now in the pipeline, as well as a panel discussion about priorities for the upcoming year.
Register
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Invitrogen names Joe Beery Senior Vice President, Chief Information Officer Invitrogen announced the appointment of Joe Beery as head of Invitrogen's Global Information Technology, effective September 8, 2008. Beery brings to Invitrogen a 25-year background in IT strategy and implementation.
Invitrogen Corporation September 05, 2008
- Acucela and Otsuka enter co-development agreement for ACU-4429 in Dry AMD Acucela and Otsuka Pharmaceutical Co. announced that they have entered into a definitive agreement to co-develop Acucela’s lead compound ACU-4429 which is currently in Phase I clinical development for the dry form of age-related macular degeneration (AMD) in the United States.
Acucela, Inc. September 04, 2008
- Acucela and Otsuka Pharmaceutical enter co-development agreement - Rebamipide Acucela and Otsuka Pharmaceutical Co. announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension, Otsuka's proprietary compound for the treatment of dry eye which is currently in Phase III clinical development in the United States.
Acucela Inc. September 04, 2008
- Abbott recognized on Dow Jones Sustainability Index (DJSI) for fourth consecutive year Abbott announced that it was recognized on the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for the fourth consecutive year.
Abbott September 04, 2008
- Amgen and Wyeth statement on the FDA Safety Announcement regarding TNF blockers Amgen and Wyeth Pharmaceuticals issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers (marketed as Remicade(R), Enbrel(R), Humira(R) and Cimzia(R)).
Amgen September 04, 2008
More... | Submit News Release | National News
|
New Job Postings...
The Recruiter’s Studio: People, Careers, Conversations
More... |
Job Advertising...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Washington's BioHistory
Why is there a biotechnology industry in Washington? Will the industry continue
to grow in Washington? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Washington BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Washington.
More...
BioEvolution Posters
More...
Your Guide to Reporting Problems to FDA
Consumers play an important public health role by reporting to the Food and
Drug Administration (FDA) any adverse events (unexpected side effects) after
using a medical product, or other problems with any products that the agency
regulates.
Timely reporting allows the agency to take prompt action. There are a
number of ways you can report problems to the agency, depending on the type of
problem and product.
More...
BioFact
(1957) - As a result of plant breeding efforts begun in 1943, Mexico becomes self-sufficient in wheat for the first time.
It's a Small World
|
| |
Lactobacillus Bacteria
| |
Science Quote
"Science is practical philosophy."
| - |
René Descartes, French philosopher, mathematician
|
|
(1596-1650)
|
|
|
|
|
|
|
